1 |
Tawfig, N. (2016) Proinflammatory cytokines and periodontal disease. J. Dent. Probl. Solut. 3: 012-017. doi: 10.17352/2394-8418.000026.
DOI
|
2 |
Socransky, S. S. and Haffajee, A. D. (1991) Microbial mechanisms in the pathogenesis of destructive periodontal diseases: A critical assessment. J. Periodont. Res. 26: 195-212.
DOI
|
3 |
Graves, D. T. and Cochran, D. (2003) The contribution of interleukin-1 and tumor necrosis factor alpha to periodontal tissue destruction. J. Periodontol. 74: 391-401.
DOI
|
4 |
Basu, A., Masek, E., and Ebersole, J. L. (2018) Dietary polyphenols and periodontitis-A mini-review of literature. Molecules 23: 1786. doi: 10.3390/molecules23071786.
DOI
|
5 |
Zhou, Q., Desta, T., Fenton, M., Graves, D. T. and Amar, S. (2005) Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect. Immun. 73: 935-943. doi: 10.1128/IAI.73.2.935-943.2005.
DOI
|
6 |
Stathopoulou, P. G., Benakanakere, M. R., Galicia, J. C. and Kinane, D. F. (2009) The host cytokine response to Porphyromonas gingivalis is modified by gingipains. Oral Microbiol. Immunol. 24: 11-17. doi: 10.1111/j.1399-302X.2008.00467.x.
DOI
|
7 |
Guo, Y., Li, Y., Xue, L., Severino, R. P., Gao, S., Niu, J., Qin, L. P. and Zhang, D. (2014) Salvia miltiorrhiza: an ancient Chinese herbal medicine as a source for anti-osteoporotic drugs. J. Ethnopharmacol. 155: 1401-1416. doi: 10.1016/j.jep.2014.07.058.
DOI
|
8 |
Bretz, W. A., Paulino, N., Nor, J. E. and Moreira, A. (2014) The effectiveness of propolis on gingivitis: a randomized controlled trial. J. Altern. Complement. Med. 20: 943-948. doi: 10.1089/acm.2013.0431.
DOI
|
9 |
Carmen, C., Lia, M. D., Alexandru, M. G. and Alina, M. H. (2020) Polyphenols of honeybee origin with applications in dental medicine. Antibiotics (Basel) 9: 856. doi: 10.3390/antibiotics9120856.
DOI
|
10 |
Zhang, J., Liang, R., Wang, L. and Yang, B. (2019) Effects and mechanisms of Danshen-Shanzha herb-pair for atherosclerosis treatment using network pharmacology and experimental pharmacology. J. Ethnopharmacol. 229: 104-114.
DOI
|
11 |
Wu, W. Y. and Wang, Y. P. (2012) Pharmacological actions and therapeutic applications of Salvia miltiorrhiza de pside salt and its active components. Acta. Pharmacol. Sin. 33: 1119-1130. doi: 10.1038/aps.2012.126. Epub 2012 Sep 3.
DOI
|
12 |
Chiang, C. Y., Tsai, H. T., Chang, W. L., Chin, Y. T., Chang, W. J., Tu, H. P., Chiu, H. C. and Fu, E. A. (2016) Salvia miltiorrhiza ethanol extract ameliorates tissue destruction caused by experimental periodontitis in rats. J. Periodontal Res. 51: 133-139. doi: 10.1111/jre.12292. Epub 2015 Jun 11.
DOI
|
13 |
Chae, H. J., Chae, S. W., Yun, D. H., Keum, K. S., Yoo, S. K. and Kim, H. R. (2004) Prevention of bone loss in ovariectomized rats: the effect of Salvia miltiorrhiza extracts. Immunopharmacol Immunotoxicol. 26: 135-144.
DOI
|
14 |
Li, M., Li, Q. Zhang, C and Zhang, N. (2013) An ethnopharmacological investigation of medicinal Salvia plants (Lamiaceae) in China. Acta Pharmaceutica Sinica B 3: 273-280.
DOI
|
15 |
Kwak, H. B., Yang, D., Ha, H., Lee, J. H., Kim, H. N., Woo, E. R., Lee, S., Kim, H. H. and Lee, Z. H. (2006) Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1. Exp. Mol. Med. 38: 256-264. doi: 10.1038/emm.2006.31.
DOI
|
16 |
Xiao, L. Q., Wang, H. T., Li, Y. L., Zeng, Q., Zhou, E., Ni, X. and Huan, Z. P. (2015) The effects of dried root aqueous extract of Salvia miltiorrhiza and its major ingredient in acceleration of orthodontic tooth movement in rat. Iran J. Basic Med. Sci. 18: 1044-1049.
|
17 |
Jang, K. A. and Kim, H. Y. (2010) Synergistic effect of methanol extract of Salvia miltiorrhiza and antibiotics against dental caries pathogens. Kor. J. Microbiol. Biotechnol. 38: 289-294.
|
18 |
Clinical and Laboratory Standards Institute (CLSI), Performance standards for antimicrobial susceptibility testing, 19th Informational Supplement. 2009. Document M100-S19, CLSI, Wayne, PA.
|
19 |
Balhaddad, A. A., Melo, M. A. S. and Gregory, R. L. (2019) Inhibition of nicotine-induced Streptococcus mutans biofilm formation by salts solutions intended for mouthrinses. Restor. Dent. Endod. 44: e4. Published online 2019 Jan 16 doi: 10.5395/rde.2019.44.e4 (2019)
DOI
|
20 |
Kinane, D. F. (1999) Periodontitis modified by systemic factors. Ann. Periodontol. 4: 54-64.
DOI
|
21 |
Min. E. G., Kim, Y. H., Keum, S. I. and Han, Y. H. (2004). Inhibition of growth and collagenase activity of the extract from Salvia miltiorrhiza against micororganisms causing periodontal disease. Kor. J. Microbiol. 40: 111-114.
|
22 |
Kubiniwa, M. and Lamont, R. J. (2010) Subgingival biofilm formation. Periodontology 52: 38-52.
DOI
|
23 |
How, K. Y., Song, K. P. and Chan, K. G. (2016) Porphorymonas gingivalis: An overview of periodontopathic pathogen below the gum line. Front. Mocrobiol. 7, 53doi: 10.3389/fmicb.2016.00053
DOI
|
24 |
Islam, B., Khan, S. N. and Khan, A. U. (2007) Dental caries: From infection to prevention. Med. Sci. Monit. 13: 196-203.
|
25 |
Noble, J. M., Scarmeas, N. and Papapanou, P. N. (2013). "Poor oral health as a chronic, potentially modifiable dementia risk factor: review of the literature". Curr. Neurol and Neurosci. Rep. 13: 384. doi:10.1007/s11910-013-0384.
DOI
|
26 |
Han, M. D., Lee, J. W., Ra, S. J. and Lee, E. S. (2000) Chemical properties of Streptococcus mutans KCTC 3065 polysaccharide purified by fractions. J. Korean Acad. Dent. Health 24: 259-270.
|
27 |
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., El-Omar, E. M., Brenner, D., Fuchs, C. S., Meyerson, M. and Garrett, W. S. (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 14: 207-215.
DOI
|
28 |
Mealey, B. L. and Rose, L. F. (2008) Diabetes mellitus and inflammatory periodontal disease. Cirr. Opion. Endocrinol. Diabetes Obes. 15: 135-141.
DOI
|
29 |
John, V., Alqallaf, H. and De Bedout, T. (2016) Periodontal disease and systemic diseases: An update for the clinician. J. Indiana Dent. Assoc. 95: 16-23.
|
30 |
Lamster, I. B. and Pagan, M. (2017) Periodontal disease and the metabolic syndrome. Int. Dent. J. 67: 67-77.
DOI
|
31 |
Jia, L., Han, N., Du, J., Guo, L., Luo, Z. and Liu, Y. (2019) Pathogenesis of important virulence factors of Porphyromonas gingivalis via toll-like receptors. Front. Cell Infect. Microbiol. 9: 262. doi: 10.3389/fcimb.2019.00262.
DOI
|
32 |
Cheng. R., Wu, Z., Li, M., Shao, M. and Hu, T. (2020) Interleukin-1beta is a potential therapeutic target for periodontitis: a narrative review. Int. J. Oral Sci. 12: 2. doi: 10.1038/s41368-019-0068-8.
DOI
|
33 |
Martinez-Aguilar, V. M., Carrillo-Avila, B. A., SauriEsquivel, E. A., Guzman-Marin, E., Jimenez-Coello, M., Escobar-Garcia, D. M. and Pozos-Guillen, A. (2019) Quantification of TNF-α in patients with periodontitis and type 2 diabetes. Biomed. Res. Int. 4;2019:7984891. doi: 10.1155/2019/7984891. eCollection 2019.
DOI
|